Amedisys Inc (AMED)

Debt-to-capital ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	361,900	366,900	369,900	373,200	419,400	443,400	442,400	429,500	432,100	434,800	179,400	231,400	204,500	300,600	392,700	379,900	232,256	231,600	266,500	303,700
Total stockholders’ equity	US$ in thousands	1,066,510	1,039,910	1,006,780	1,079,120	1,051,570	1,015,740	985,646	966,758	931,351	905,264	874,272	788,153	809,224	756,205	720,851	679,197	640,450	602,564	561,781	520,246
Debt-to-capital ratio		0.25	0.26	0.27	0.26	0.29	0.30	0.31	0.31	0.32	0.32	0.17	0.23	0.20	0.28	0.35	0.36	0.27	0.28	0.32	0.37

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $361,900K ÷ ($361,900K + $1,066,510K)
= 0.25

Amedisys Inc.'s debt-to-capital ratio has exhibited fluctuations over the past 8 quarters. The company's debt-to-capital ratio ranged from 0.27 to 0.32 during this period. Overall, the trend appears to be relatively stable, with minor variations observed. Despite some quarterly fluctuations, the debt-to-capital ratio has generally remained within a narrow range, indicating a consistent capital structure strategy. The most recent quarter, Q4 2023, shows a slight decrease in the ratio compared to the previous quarters, which may imply a reduction in the company's reliance on debt financing relative to its total capital. Further analysis and comparison with industry benchmarks could provide additional insights into Amedisys Inc.'s leverage position and financial health.